nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—type 2 diabetes mellitus	0.336	1	CbGaD
Tiagabine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0544	0.152	CbGbCtD
Tiagabine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0485	0.136	CbGbCtD
Tiagabine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0443	0.124	CbGbCtD
Tiagabine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0387	0.109	CbGbCtD
Tiagabine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.035	0.0982	CbGbCtD
Tiagabine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0265	0.0744	CbGbCtD
Tiagabine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0255	0.0713	CbGbCtD
Tiagabine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0255	0.0713	CbGbCtD
Tiagabine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0241	0.0675	CbGbCtD
Tiagabine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0179	0.0503	CbGbCtD
Tiagabine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0164	0.046	CbGbCtD
Tiagabine—SLC6A1—GABA synthesis, release, reuptake and degradation—GAD2—type 2 diabetes mellitus	0.00565	0.074	CbGpPWpGaD
Tiagabine—SLC6A1—GABA synthesis, release, reuptake and degradation—SNAP25—type 2 diabetes mellitus	0.00364	0.0477	CbGpPWpGaD
Tiagabine—SLC6A1—Neurotransmitter Release Cycle—GAD2—type 2 diabetes mellitus	0.003	0.0392	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.00223	0.0292	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—NOS1—type 2 diabetes mellitus	0.00214	0.028	CbGpPWpGaD
Tiagabine—SLC6A1—Neurotransmitter Release Cycle—SNAP25—type 2 diabetes mellitus	0.00193	0.0253	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.00176	0.023	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.00169	0.0221	CbGpPWpGaD
Tiagabine—CYP3A4—Felbamate Metabolism—CYP2E1—type 2 diabetes mellitus	0.00169	0.0221	CbGpPWpGaD
Tiagabine—CYP3A4—Lidocaine metabolism—CYP1A2—type 2 diabetes mellitus	0.00167	0.0218	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.00161	0.021	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.00152	0.0199	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNK16—type 2 diabetes mellitus	0.00143	0.0188	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—AGT—type 2 diabetes mellitus	0.0014	0.0183	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	0.00122	0.0159	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.00115	0.0151	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.00101	0.0133	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.000995	0.013	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000978	0.0128	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—ABCC2—type 2 diabetes mellitus	0.000959	0.0126	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.00086	0.0113	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000857	0.0112	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	0.000832	0.0109	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—ABCC2—type 2 diabetes mellitus	0.000819	0.0107	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000798	0.0104	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000772	0.0101	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000768	0.01	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000754	0.00987	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GAD2—type 2 diabetes mellitus	0.000659	0.00862	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000653	0.00854	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.000645	0.00844	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TNF—type 2 diabetes mellitus	0.000633	0.00829	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.00063	0.00825	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.000618	0.00809	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—type 2 diabetes mellitus	0.000612	0.00801	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000596	0.0078	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000554	0.00725	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.000538	0.00704	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.00053	0.00694	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000525	0.00687	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—ABCC2—type 2 diabetes mellitus	0.000523	0.00685	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000515	0.00674	CbGpPWpGaD
Tiagabine—CYP3A4—Liver X Receptor Pathway—SREBF1—type 2 diabetes mellitus	0.000509	0.00666	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000501	0.00655	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000497	0.00651	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000497	0.00651	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTM1—type 2 diabetes mellitus	0.000494	0.00647	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000489	0.0064	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—AGER—type 2 diabetes mellitus	0.000476	0.00624	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—type 2 diabetes mellitus	0.000469	0.00614	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000455	0.00595	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYB5R4—type 2 diabetes mellitus	0.000454	0.00595	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—type 2 diabetes mellitus	0.000448	0.00586	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000425	0.00556	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000414	0.00542	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000406	0.00532	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.000406	0.00531	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000405	0.0053	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000405	0.0053	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.00039	0.00511	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.00039	0.00511	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000389	0.0051	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000383	0.00502	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000369	0.00483	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000354	0.00464	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.000337	0.00441	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000332	0.00434	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000331	0.00433	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.00032	0.00419	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—type 2 diabetes mellitus	0.00032	0.00418	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GNB3—type 2 diabetes mellitus	0.000317	0.00415	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000317	0.00415	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—type 2 diabetes mellitus	0.000316	0.00414	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000307	0.00402	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000298	0.0039	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—CYP1A2—type 2 diabetes mellitus	0.000288	0.00376	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000283	0.0037	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—type 2 diabetes mellitus	0.000275	0.00361	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	0.00027	0.00354	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP2E1—type 2 diabetes mellitus	0.000267	0.0035	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000267	0.00349	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP1A2—type 2 diabetes mellitus	0.000264	0.00346	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	0.000257	0.00337	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP2E1—type 2 diabetes mellitus	0.000257	0.00337	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000255	0.00333	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000255	0.00333	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP1A2—type 2 diabetes mellitus	0.000254	0.00333	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000248	0.00325	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000247	0.00323	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000246	0.00321	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CALM1—type 2 diabetes mellitus	0.000243	0.00318	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000228	0.00299	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—type 2 diabetes mellitus	0.000228	0.00298	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.00022	0.00289	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000216	0.00283	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000206	0.0027	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFB1—type 2 diabetes mellitus	0.000201	0.00264	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.000201	0.00263	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000198	0.00259	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	0.000178	0.00232	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000175	0.00229	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000173	0.00226	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000171	0.00223	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.00017	0.00222	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000168	0.0022	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000163	0.00213	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000152	0.00199	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.00015	0.00196	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.000137	0.0018	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000137	0.0018	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.000136	0.00178	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000135	0.00176	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.000133	0.00174	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000129	0.00168	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.000118	0.00154	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	0.000115	0.0015	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	0.000111	0.00145	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	0.00011	0.00144	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	0.00011	0.00144	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	0.00011	0.00143	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.000109	0.00143	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	0.000108	0.00142	CbGpPWpGaD
Tiagabine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000105	0.000456	CcSEcCtD
Tiagabine—Cough—Irbesartan—type 2 diabetes mellitus	0.000105	0.000456	CcSEcCtD
Tiagabine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000105	0.000456	CcSEcCtD
Tiagabine—Anaemia—Losartan—type 2 diabetes mellitus	0.000105	0.000455	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000104	0.000452	CcSEcCtD
Tiagabine—Agitation—Losartan—type 2 diabetes mellitus	0.000104	0.000452	CcSEcCtD
Tiagabine—Oedema—Metformin—type 2 diabetes mellitus	0.000104	0.000452	CcSEcCtD
Tiagabine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000104	0.000452	CcSEcCtD
Tiagabine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000104	0.000451	CcSEcCtD
Tiagabine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000104	0.00045	CcSEcCtD
Tiagabine—Infection—Metformin—type 2 diabetes mellitus	0.000104	0.000449	CcSEcCtD
Tiagabine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000104	0.000449	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000103	0.000447	CcSEcCtD
Tiagabine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000103	0.000446	CcSEcCtD
Tiagabine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000103	0.000445	CcSEcCtD
Tiagabine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000445	CcSEcCtD
Tiagabine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000103	0.000445	CcSEcCtD
Tiagabine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000445	CcSEcCtD
Tiagabine—Shock—Metformin—type 2 diabetes mellitus	0.000103	0.000445	CcSEcCtD
Tiagabine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000102	0.000444	CcSEcCtD
Tiagabine—Malaise—Losartan—type 2 diabetes mellitus	0.000102	0.000444	CcSEcCtD
Tiagabine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000102	0.000443	CcSEcCtD
Tiagabine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000102	0.000443	CcSEcCtD
Tiagabine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000102	0.000443	CcSEcCtD
Tiagabine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000102	0.000443	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000102	0.00133	CbGpPWpGaD
Tiagabine—Vertigo—Losartan—type 2 diabetes mellitus	0.000102	0.000442	CcSEcCtD
Tiagabine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000102	0.000442	CcSEcCtD
Tiagabine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000102	0.000441	CcSEcCtD
Tiagabine—Syncope—Losartan—type 2 diabetes mellitus	0.000102	0.000441	CcSEcCtD
Tiagabine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000102	0.00044	CcSEcCtD
Tiagabine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000102	0.00044	CcSEcCtD
Tiagabine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000101	0.00044	CcSEcCtD
Tiagabine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000101	0.000437	CcSEcCtD
Tiagabine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000101	0.000437	CcSEcCtD
Tiagabine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.0001	0.000435	CcSEcCtD
Tiagabine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.0001	0.000435	CcSEcCtD
Tiagabine—Palpitations—Losartan—type 2 diabetes mellitus	0.0001	0.000435	CcSEcCtD
Tiagabine—Nausea—Glimepiride—type 2 diabetes mellitus	9.99e-05	0.000433	CcSEcCtD
Tiagabine—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.97e-05	0.000432	CcSEcCtD
Tiagabine—Nausea—Sitagliptin—type 2 diabetes mellitus	9.96e-05	0.000432	CcSEcCtD
Tiagabine—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.96e-05	0.000432	CcSEcCtD
Tiagabine—Asthenia—Glyburide—type 2 diabetes mellitus	9.95e-05	0.000432	CcSEcCtD
Tiagabine—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.95e-05	0.000431	CcSEcCtD
Tiagabine—Anorexia—Metformin—type 2 diabetes mellitus	9.94e-05	0.000431	CcSEcCtD
Tiagabine—Cough—Losartan—type 2 diabetes mellitus	9.9e-05	0.000429	CcSEcCtD
Tiagabine—Urticaria—Gliclazide—type 2 diabetes mellitus	9.9e-05	0.000429	CcSEcCtD
Tiagabine—Alopecia—Ramipril—type 2 diabetes mellitus	9.87e-05	0.000428	CcSEcCtD
Tiagabine—Fatigue—Valsartan—type 2 diabetes mellitus	9.87e-05	0.000428	CcSEcCtD
Tiagabine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.85e-05	0.000427	CcSEcCtD
Tiagabine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.85e-05	0.000427	CcSEcCtD
Tiagabine—Oedema—Irbesartan—type 2 diabetes mellitus	9.84e-05	0.000427	CcSEcCtD
Tiagabine—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000426	CcSEcCtD
Tiagabine—Pruritus—Glyburide—type 2 diabetes mellitus	9.82e-05	0.000426	CcSEcCtD
Tiagabine—Constipation—Valsartan—type 2 diabetes mellitus	9.79e-05	0.000424	CcSEcCtD
Tiagabine—Infection—Irbesartan—type 2 diabetes mellitus	9.77e-05	0.000424	CcSEcCtD
Tiagabine—Fatigue—Orlistat—type 2 diabetes mellitus	9.75e-05	0.000423	CcSEcCtD
Tiagabine—Hypotension—Metformin—type 2 diabetes mellitus	9.74e-05	0.000422	CcSEcCtD
Tiagabine—Shock—Irbesartan—type 2 diabetes mellitus	9.68e-05	0.00042	CcSEcCtD
Tiagabine—Pain—Orlistat—type 2 diabetes mellitus	9.67e-05	0.000419	CcSEcCtD
Tiagabine—Myalgia—Losartan—type 2 diabetes mellitus	9.66e-05	0.000419	CcSEcCtD
Tiagabine—Chest pain—Losartan—type 2 diabetes mellitus	9.66e-05	0.000419	CcSEcCtD
Tiagabine—Arthralgia—Losartan—type 2 diabetes mellitus	9.66e-05	0.000419	CcSEcCtD
Tiagabine—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.65e-05	0.000418	CcSEcCtD
Tiagabine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.000418	CcSEcCtD
Tiagabine—Anxiety—Losartan—type 2 diabetes mellitus	9.62e-05	0.000417	CcSEcCtD
Tiagabine—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.6e-05	0.000416	CcSEcCtD
Tiagabine—Rash—Bromocriptine—type 2 diabetes mellitus	9.57e-05	0.000415	CcSEcCtD
Tiagabine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.56e-05	0.000415	CcSEcCtD
Tiagabine—Tension—Ramipril—type 2 diabetes mellitus	9.54e-05	0.000414	CcSEcCtD
Tiagabine—Discomfort—Losartan—type 2 diabetes mellitus	9.54e-05	0.000414	CcSEcCtD
Tiagabine—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.52e-05	0.000413	CcSEcCtD
Tiagabine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000412	CcSEcCtD
Tiagabine—Headache—Bromocriptine—type 2 diabetes mellitus	9.51e-05	0.000412	CcSEcCtD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	9.5e-05	0.00124	CbGpPWpGaD
Tiagabine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.5e-05	0.000412	CcSEcCtD
Tiagabine—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.49e-05	0.000412	CcSEcCtD
Tiagabine—Nervousness—Ramipril—type 2 diabetes mellitus	9.45e-05	0.00041	CcSEcCtD
Tiagabine—Dry mouth—Losartan—type 2 diabetes mellitus	9.44e-05	0.00041	CcSEcCtD
Tiagabine—Anorexia—Irbesartan—type 2 diabetes mellitus	9.38e-05	0.000407	CcSEcCtD
Tiagabine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.36e-05	0.000406	CcSEcCtD
Tiagabine—Paraesthesia—Metformin—type 2 diabetes mellitus	9.36e-05	0.000406	CcSEcCtD
Tiagabine—Muscle spasms—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000405	CcSEcCtD
Tiagabine—Confusional state—Losartan—type 2 diabetes mellitus	9.33e-05	0.000405	CcSEcCtD
Tiagabine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.32e-05	0.000404	CcSEcCtD
Tiagabine—Dyspnoea—Metformin—type 2 diabetes mellitus	9.29e-05	0.000403	CcSEcCtD
Tiagabine—Somnolence—Metformin—type 2 diabetes mellitus	9.27e-05	0.000402	CcSEcCtD
Tiagabine—Oedema—Losartan—type 2 diabetes mellitus	9.26e-05	0.000401	CcSEcCtD
Tiagabine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.25e-05	0.000401	CcSEcCtD
Tiagabine—Infection—Losartan—type 2 diabetes mellitus	9.2e-05	0.000399	CcSEcCtD
Tiagabine—Hypotension—Irbesartan—type 2 diabetes mellitus	9.19e-05	0.000399	CcSEcCtD
Tiagabine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.18e-05	0.000398	CcSEcCtD
Tiagabine—Dyspepsia—Metformin—type 2 diabetes mellitus	9.18e-05	0.000398	CcSEcCtD
Tiagabine—Tremor—Ramipril—type 2 diabetes mellitus	9.11e-05	0.000395	CcSEcCtD
Tiagabine—Shock—Losartan—type 2 diabetes mellitus	9.11e-05	0.000395	CcSEcCtD
Tiagabine—Urticaria—Valsartan—type 2 diabetes mellitus	9.09e-05	0.000394	CcSEcCtD
Tiagabine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.06e-05	0.000393	CcSEcCtD
Tiagabine—Decreased appetite—Metformin—type 2 diabetes mellitus	9.06e-05	0.000393	CcSEcCtD
Tiagabine—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.05e-05	0.000392	CcSEcCtD
Tiagabine—Tachycardia—Losartan—type 2 diabetes mellitus	9.04e-05	0.000392	CcSEcCtD
Tiagabine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000391	CcSEcCtD
Tiagabine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.02e-05	0.000391	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	9e-05	0.00118	CbGpPWpGaD
Tiagabine—Fatigue—Metformin—type 2 diabetes mellitus	8.99e-05	0.00039	CcSEcCtD
Tiagabine—Urticaria—Orlistat—type 2 diabetes mellitus	8.99e-05	0.00039	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.96e-05	0.000389	CcSEcCtD
Tiagabine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.95e-05	0.000388	CcSEcCtD
Tiagabine—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.94e-05	0.000388	CcSEcCtD
Tiagabine—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.94e-05	0.000388	CcSEcCtD
Tiagabine—Asthenia—Gliclazide—type 2 diabetes mellitus	8.94e-05	0.000388	CcSEcCtD
Tiagabine—Agitation—Ramipril—type 2 diabetes mellitus	8.94e-05	0.000388	CcSEcCtD
Tiagabine—Constipation—Metformin—type 2 diabetes mellitus	8.91e-05	0.000387	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	8.9e-05	0.00116	CbGpPWpGaD
Tiagabine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.83e-05	0.000383	CcSEcCtD
Tiagabine—Anorexia—Losartan—type 2 diabetes mellitus	8.82e-05	0.000383	CcSEcCtD
Tiagabine—Vomiting—Glyburide—type 2 diabetes mellitus	8.82e-05	0.000383	CcSEcCtD
Tiagabine—Pruritus—Gliclazide—type 2 diabetes mellitus	8.81e-05	0.000382	CcSEcCtD
Tiagabine—Malaise—Ramipril—type 2 diabetes mellitus	8.77e-05	0.00038	CcSEcCtD
Tiagabine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.77e-05	0.00038	CcSEcCtD
Tiagabine—Rash—Glyburide—type 2 diabetes mellitus	8.75e-05	0.000379	CcSEcCtD
Tiagabine—Somnolence—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000379	CcSEcCtD
Tiagabine—Dermatitis—Glyburide—type 2 diabetes mellitus	8.74e-05	0.000379	CcSEcCtD
Tiagabine—Vertigo—Ramipril—type 2 diabetes mellitus	8.74e-05	0.000379	CcSEcCtD
Tiagabine—Syncope—Ramipril—type 2 diabetes mellitus	8.72e-05	0.000378	CcSEcCtD
Tiagabine—Leukopenia—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000378	CcSEcCtD
Tiagabine—Headache—Glyburide—type 2 diabetes mellitus	8.69e-05	0.000377	CcSEcCtD
Tiagabine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.66e-05	0.000375	CcSEcCtD
Tiagabine—Hypotension—Losartan—type 2 diabetes mellitus	8.65e-05	0.000375	CcSEcCtD
Tiagabine—Palpitations—Ramipril—type 2 diabetes mellitus	8.6e-05	0.000373	CcSEcCtD
Tiagabine—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.59e-05	0.000372	CcSEcCtD
Tiagabine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000371	CcSEcCtD
Tiagabine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.55e-05	0.000371	CcSEcCtD
Tiagabine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.52e-05	0.00037	CcSEcCtD
Tiagabine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.52e-05	0.00037	CcSEcCtD
Tiagabine—Cough—Ramipril—type 2 diabetes mellitus	8.49e-05	0.000368	CcSEcCtD
Tiagabine—Fatigue—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000368	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.43e-05	0.000366	CcSEcCtD
Tiagabine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.43e-05	0.000366	CcSEcCtD
Tiagabine—Constipation—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.000365	CcSEcCtD
Tiagabine—Pain—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.000365	CcSEcCtD
Tiagabine—Insomnia—Losartan—type 2 diabetes mellitus	8.37e-05	0.000363	CcSEcCtD
Tiagabine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.33e-05	0.000361	CcSEcCtD
Tiagabine—Paraesthesia—Losartan—type 2 diabetes mellitus	8.31e-05	0.00036	CcSEcCtD
Tiagabine—Urticaria—Metformin—type 2 diabetes mellitus	8.28e-05	0.000359	CcSEcCtD
Tiagabine—Myalgia—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000359	CcSEcCtD
Tiagabine—Arthralgia—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000359	CcSEcCtD
Tiagabine—Chest pain—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000359	CcSEcCtD
Tiagabine—Dyspnoea—Losartan—type 2 diabetes mellitus	8.25e-05	0.000358	CcSEcCtD
Tiagabine—Anxiety—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000358	CcSEcCtD
Tiagabine—Nausea—Glyburide—type 2 diabetes mellitus	8.24e-05	0.000357	CcSEcCtD
Tiagabine—Abdominal pain—Metformin—type 2 diabetes mellitus	8.24e-05	0.000357	CcSEcCtD
Tiagabine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.24e-05	0.000357	CcSEcCtD
Tiagabine—Somnolence—Losartan—type 2 diabetes mellitus	8.23e-05	0.000357	CcSEcCtD
Tiagabine—Asthenia—Valsartan—type 2 diabetes mellitus	8.21e-05	0.000356	CcSEcCtD
Tiagabine—Discomfort—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000355	CcSEcCtD
Tiagabine—Dyspepsia—Losartan—type 2 diabetes mellitus	8.15e-05	0.000353	CcSEcCtD
Tiagabine—Asthenia—Orlistat—type 2 diabetes mellitus	8.12e-05	0.000352	CcSEcCtD
Tiagabine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.11e-05	0.000352	CcSEcCtD
Tiagabine—Pruritus—Valsartan—type 2 diabetes mellitus	8.1e-05	0.000351	CcSEcCtD
Tiagabine—Dry mouth—Ramipril—type 2 diabetes mellitus	8.1e-05	0.000351	CcSEcCtD
Tiagabine—Decreased appetite—Losartan—type 2 diabetes mellitus	8.05e-05	0.000349	CcSEcCtD
Tiagabine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000349	CcSEcCtD
Tiagabine—Confusional state—Ramipril—type 2 diabetes mellitus	8e-05	0.000347	CcSEcCtD
Tiagabine—Pruritus—Orlistat—type 2 diabetes mellitus	8e-05	0.000347	CcSEcCtD
Tiagabine—Fatigue—Losartan—type 2 diabetes mellitus	7.98e-05	0.000346	CcSEcCtD
Tiagabine—Oedema—Ramipril—type 2 diabetes mellitus	7.94e-05	0.000344	CcSEcCtD
Tiagabine—Vomiting—Gliclazide—type 2 diabetes mellitus	7.92e-05	0.000344	CcSEcCtD
Tiagabine—Constipation—Losartan—type 2 diabetes mellitus	7.92e-05	0.000343	CcSEcCtD
Tiagabine—Pain—Losartan—type 2 diabetes mellitus	7.92e-05	0.000343	CcSEcCtD
Tiagabine—Rash—Gliclazide—type 2 diabetes mellitus	7.86e-05	0.000341	CcSEcCtD
Tiagabine—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.85e-05	0.00034	CcSEcCtD
Tiagabine—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.83e-05	0.00034	CcSEcCtD
Tiagabine—Urticaria—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000339	CcSEcCtD
Tiagabine—Shock—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000339	CcSEcCtD
Tiagabine—Headache—Gliclazide—type 2 diabetes mellitus	7.8e-05	0.000338	CcSEcCtD
Tiagabine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000337	CcSEcCtD
Tiagabine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000337	CcSEcCtD
Tiagabine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000337	CcSEcCtD
Tiagabine—Tachycardia—Ramipril—type 2 diabetes mellitus	7.75e-05	0.000336	CcSEcCtD
Tiagabine—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.74e-05	0.000336	CcSEcCtD
Tiagabine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000333	CcSEcCtD
Tiagabine—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.63e-05	0.000331	CcSEcCtD
Tiagabine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.57e-05	0.000328	CcSEcCtD
Tiagabine—Dizziness—Valsartan—type 2 diabetes mellitus	7.57e-05	0.000328	CcSEcCtD
Tiagabine—Anorexia—Ramipril—type 2 diabetes mellitus	7.57e-05	0.000328	CcSEcCtD
Tiagabine—Dizziness—Orlistat—type 2 diabetes mellitus	7.48e-05	0.000324	CcSEcCtD
Tiagabine—Asthenia—Metformin—type 2 diabetes mellitus	7.48e-05	0.000324	CcSEcCtD
Tiagabine—Hypotension—Ramipril—type 2 diabetes mellitus	7.42e-05	0.000322	CcSEcCtD
Tiagabine—Nausea—Gliclazide—type 2 diabetes mellitus	7.4e-05	0.000321	CcSEcCtD
Tiagabine—Pruritus—Metformin—type 2 diabetes mellitus	7.37e-05	0.00032	CcSEcCtD
Tiagabine—Urticaria—Losartan—type 2 diabetes mellitus	7.35e-05	0.000319	CcSEcCtD
Tiagabine—Abdominal pain—Losartan—type 2 diabetes mellitus	7.32e-05	0.000317	CcSEcCtD
Tiagabine—Body temperature increased—Losartan—type 2 diabetes mellitus	7.32e-05	0.000317	CcSEcCtD
Tiagabine—Vomiting—Valsartan—type 2 diabetes mellitus	7.28e-05	0.000316	CcSEcCtD
Tiagabine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.25e-05	0.000314	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.23e-05	0.000314	CcSEcCtD
Tiagabine—Rash—Valsartan—type 2 diabetes mellitus	7.22e-05	0.000313	CcSEcCtD
Tiagabine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.21e-05	0.000313	CcSEcCtD
Tiagabine—Vomiting—Orlistat—type 2 diabetes mellitus	7.19e-05	0.000312	CcSEcCtD
Tiagabine—Insomnia—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000311	CcSEcCtD
Tiagabine—Headache—Valsartan—type 2 diabetes mellitus	7.17e-05	0.000311	CcSEcCtD
Tiagabine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.13e-05	0.000309	CcSEcCtD
Tiagabine—Rash—Orlistat—type 2 diabetes mellitus	7.13e-05	0.000309	CcSEcCtD
Tiagabine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.13e-05	0.000309	CcSEcCtD
Tiagabine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.12e-05	0.000309	CcSEcCtD
Tiagabine—Headache—Orlistat—type 2 diabetes mellitus	7.09e-05	0.000307	CcSEcCtD
Tiagabine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000307	CcSEcCtD
Tiagabine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.06e-05	0.000306	CcSEcCtD
Tiagabine—Somnolence—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000306	CcSEcCtD
Tiagabine—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000303	CcSEcCtD
Tiagabine—Pruritus—Irbesartan—type 2 diabetes mellitus	6.96e-05	0.000302	CcSEcCtD
Tiagabine—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000299	CcSEcCtD
Tiagabine—Dizziness—Metformin—type 2 diabetes mellitus	6.89e-05	0.000299	CcSEcCtD
Tiagabine—Fatigue—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000297	CcSEcCtD
Tiagabine—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.82e-05	0.000296	CcSEcCtD
Tiagabine—Nausea—Valsartan—type 2 diabetes mellitus	6.8e-05	0.000295	CcSEcCtD
Tiagabine—Constipation—Ramipril—type 2 diabetes mellitus	6.79e-05	0.000294	CcSEcCtD
Tiagabine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.000292	CcSEcCtD
Tiagabine—Nausea—Orlistat—type 2 diabetes mellitus	6.72e-05	0.000291	CcSEcCtD
Tiagabine—Asthenia—Losartan—type 2 diabetes mellitus	6.64e-05	0.000288	CcSEcCtD
Tiagabine—Vomiting—Metformin—type 2 diabetes mellitus	6.63e-05	0.000287	CcSEcCtD
Tiagabine—Rash—Metformin—type 2 diabetes mellitus	6.57e-05	0.000285	CcSEcCtD
Tiagabine—Dermatitis—Metformin—type 2 diabetes mellitus	6.57e-05	0.000285	CcSEcCtD
Tiagabine—Pruritus—Losartan—type 2 diabetes mellitus	6.55e-05	0.000284	CcSEcCtD
Tiagabine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000284	CcSEcCtD
Tiagabine—Headache—Metformin—type 2 diabetes mellitus	6.53e-05	0.000283	CcSEcCtD
Tiagabine—Dizziness—Irbesartan—type 2 diabetes mellitus	6.5e-05	0.000282	CcSEcCtD
Tiagabine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000281	CcSEcCtD
Tiagabine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.33e-05	0.000275	CcSEcCtD
Tiagabine—Urticaria—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000273	CcSEcCtD
Tiagabine—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000272	CcSEcCtD
Tiagabine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000272	CcSEcCtD
Tiagabine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000271	CcSEcCtD
Tiagabine—Rash—Irbesartan—type 2 diabetes mellitus	6.2e-05	0.000269	CcSEcCtD
Tiagabine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.2e-05	0.000269	CcSEcCtD
Tiagabine—Nausea—Metformin—type 2 diabetes mellitus	6.19e-05	0.000268	CcSEcCtD
Tiagabine—Headache—Irbesartan—type 2 diabetes mellitus	6.16e-05	0.000267	CcSEcCtD
Tiagabine—Dizziness—Losartan—type 2 diabetes mellitus	6.12e-05	0.000265	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	5.98e-05	0.000783	CbGpPWpGaD
Tiagabine—Vomiting—Losartan—type 2 diabetes mellitus	5.89e-05	0.000255	CcSEcCtD
Tiagabine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.85e-05	0.000254	CcSEcCtD
Tiagabine—Nausea—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000253	CcSEcCtD
Tiagabine—Rash—Losartan—type 2 diabetes mellitus	5.84e-05	0.000253	CcSEcCtD
Tiagabine—Dermatitis—Losartan—type 2 diabetes mellitus	5.83e-05	0.000253	CcSEcCtD
Tiagabine—Headache—Losartan—type 2 diabetes mellitus	5.8e-05	0.000251	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	5.79e-05	0.000758	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	5.71e-05	0.000748	CbGpPWpGaD
Tiagabine—Asthenia—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000247	CcSEcCtD
Tiagabine—Pruritus—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000244	CcSEcCtD
Tiagabine—Nausea—Losartan—type 2 diabetes mellitus	5.5e-05	0.000238	CcSEcCtD
Tiagabine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000236	CcSEcCtD
Tiagabine—Dizziness—Ramipril—type 2 diabetes mellitus	5.25e-05	0.000228	CcSEcCtD
Tiagabine—Vomiting—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000219	CcSEcCtD
Tiagabine—Rash—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000217	CcSEcCtD
Tiagabine—Dermatitis—Ramipril—type 2 diabetes mellitus	5e-05	0.000217	CcSEcCtD
Tiagabine—Headache—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000216	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	4.78e-05	0.000626	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	4.73e-05	0.000619	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	4.72e-05	0.000617	CbGpPWpGaD
Tiagabine—Nausea—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000204	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	4.66e-05	0.00061	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	3.62e-05	0.000474	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	3.57e-05	0.000468	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.76e-05	0.000362	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	2.42e-05	0.000316	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	2.42e-05	0.000316	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	2.29e-05	0.0003	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	2.29e-05	0.0003	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	2.18e-05	0.000286	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	2.02e-05	0.000264	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	2.02e-05	0.000264	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.95e-05	0.000255	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.95e-05	0.000255	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.95e-05	0.000255	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.95e-05	0.000255	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.95e-05	0.000255	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.89e-05	0.000247	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.78e-05	0.000233	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.78e-05	0.000233	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.74e-05	0.000227	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.66e-05	0.000217	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.66e-05	0.000217	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.66e-05	0.000217	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.59e-05	0.000208	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.59e-05	0.000208	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.53e-05	0.0002	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.53e-05	0.0002	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.5e-05	0.000196	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.48e-05	0.000193	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.48e-05	0.000193	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.48e-05	0.000193	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.39e-05	0.000182	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.3e-05	0.00017	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.25e-05	0.000164	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.25e-05	0.000164	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.25e-05	0.000164	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.25e-05	0.000164	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.2e-05	0.000157	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.12e-05	0.000146	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.04e-05	0.000137	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.02e-05	0.000134	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.02e-05	0.000134	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1e-05	0.000131	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	9.97e-06	0.00013	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	9.97e-06	0.00013	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	9.97e-06	0.00013	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	9.91e-06	0.00013	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	9.73e-06	0.000127	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	9.62e-06	0.000126	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	8.94e-06	0.000117	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	8.94e-06	0.000117	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	8.94e-06	0.000117	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	8.78e-06	0.000115	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	8.7e-06	0.000114	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	8.51e-06	0.000111	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	8.18e-06	0.000107	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	8.09e-06	0.000106	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	8.09e-06	0.000106	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	7.75e-06	0.000101	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	7.75e-06	0.000101	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	6.68e-06	8.74e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.68e-06	8.74e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	6.65e-06	8.7e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	6.56e-06	8.59e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	6.37e-06	8.34e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	6.2e-06	8.11e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	6.08e-06	7.96e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.96e-06	7.79e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.93e-06	7.77e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.78e-06	7.56e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.71e-06	7.47e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	5.48e-06	7.17e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	5.37e-06	7.03e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	5.2e-06	6.81e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	5.12e-06	6.7e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	5.1e-06	6.67e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	5.04e-06	6.6e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	4.44e-06	5.81e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	4.36e-06	5.7e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.99e-06	5.23e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.82e-06	5e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.82e-06	5e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.49e-06	4.57e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.76e-06	2.3e-05	CbGpPWpGaD
